COVID-19 updates: Classes in Chicago canceled for 4th day
Chicago Public Schools has been in talks with teachers over COVID-19 safety.
As the COVID-19 pandemic has swept the globe, more than 5.4 million people have died from the disease worldwide, including over 837,000 Americans, according to real-time data compiled by Johns Hopkins University's Center for Systems Science and Engineering.
About 62.5% of the population in the United States is fully vaccinated against COVID-19, according to data from the Centers for Disease Control and Prevention.
Latest headlines:
- 1 in 5 Americans have tested positive for COVID-19
- Half of NYC COVID hospitalized patients were admitted for other reasons
- COVID vaccines can cause temporary menstrual cycle changes: Study
- CDC director responds to criticism of COVID-19 guidance
- Florida allowed up to 1 million COVID-19 tests to expire, official says
Israel approves 4th vaccine dose for people 60 and over
Israel's Ministry of Health approved a fourth dose of COVID-19 vaccine for health care workers and people over 60 years old, Prime Minister Naftali Bennett said.
"Israel will once again be pioneering the global vaccination effort," Bennett said at a press conference in Jerusalem. "Omicron is not Delta -- it’s a different ball-game altogether."
Fourth doses will be administered four months after booster shots, Bennett said.
ABC News' Jordana Miller
White House confident it can deliver 500 million COVID tests this month
The White House said Wednesday it is confident it can deliver millions of rapid COVID-19 tests to Americans in January.
Last month, the administration announced it was planning to distribute 500 million free at-home rapid tests across the country to combat the surging omicron variant.
However, a website has yet to be launched where people can order the tests and the U.S. is currently producing less than half of the tests needed -- 200 million a month.
During a virtual briefing, Jeff Zients, the White House Coronavirus Response Coordinator, said the government not only has the capacity to deliver 500 million tests, but it also won't dip into the current supply on pharmacy shelves.
"With all the companies that now have been authorized, there’s the capacity for the U.S. government to purchase the 500 million now and not disrupt, or in any way cannibalize, the tests that are on pharmacy shelves and on websites and used and other settings," he said.
-ABC News' Cheyenne Haslett